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During autumn 2005, we conducted 3,436 interviews
in European and Asian countries. We found risk percep-
tions of avian influenza to be at an intermediate level and
beliefs of efficacy to be slightly lower. Risk perceptions
were higher in Asia than Europe; efficacy beliefs were lower
in Europe than in Asia. 
T
he possibility of an influenza pandemic presents a
major public health challenge. Since 2003, outbreaks of
avian influenza (AI) have occurred in Asian, European, and
African countries. As of August 21, 2006, the total number
of cases was 240 and the number of deaths was 141 (1). A
crossover of current human influenza virus with the avian
H5N1 virus could result in a virus capable of human-to-
human transmission and the start of a new pandemic.
Despite extensive media attention for avian influenza,
knowledge about risk perception of AI is scarce. We there-
fore explored the conditions for effective nonmedical
interventions. If an influenza pandemic occurs, public
health authorities will be dependent on the willingness and
ability of the public to adhere to recommendations regard-
ing personal hygiene, vaccination and prophylaxis, quar-
antine, travel restrictions, or closing of public buildings
(2,3). Adherence, however, cannot be assumed. Evaluation
of the outbreak of H7N7 AI in the Netherlands in 2003
showed that adherence to antiviral therapy and behavioral
measures, such as wearing face masks and goggles, was
low (4).
Our ability to promote health-protective behavioral
change depends on our knowledge of determinants of such
behavior (5). The protection motivation theory posits that
health-protective actions are influenced by risk percep-
tions (6–8). Risk perceptions are defined by the perceived
seriousness of a health threat and perceived personal
vulnerability. However, the protection motivation theory
explicitly states that higher risk perceptions will only pre-
dict protective behavior when people believe that effective
protective actions are available (response efficacy) and
that they have the ability to engage in such protective
actions (self-efficacy).
The Study
We investigated risk perceptions and efficacy beliefs
related to AI of a random sample of persons in 8 areas.
Random digital dialing was used to select the samples, and
data were collected by using computer-assisted telephone
interviewing. Interviews were conducted from September
20 through November 22, 2005, in 5 European countries
(Denmark, the Netherlands, United Kingdom, Spain, and
Poland) and 3 East Asian areas (Singapore; Guangdong
Province, People’s Republic of China; and Hong Kong,
Special Administrative Region, People’s Republic of
China). At the time the telephone survey was conducted,
on October 14, 2005, the media announced the introduc-
tion of AI in Europe. We therefore ensured that at least 90
interviews were conducted in each country after October
18, 2005. The questionnaire focused on risk perception of
AI and other infectious diseases, precautionary behavior,
and use of information sources; it was based on our earlier
study of risk perception of severe acute respiratory syn-
drome (SARS) (9). Respondents first received a brief
explanation of AI.
In line with the protection motivation theory (8), a
measure of risk perception was constructed by multiplica-
tion of seriousness (scale 1–10) and vulnerability (scale
1–5). To make the scores comparable, the seriousness
score was first divided by 2. To normalize the skewed dis-
tribution of the new variable, a square-root transformation
was performed, which resulted in a measure of risk percep-
tion on a scale from 1 (low) to 5 (high).
Atotal of 3,436 respondents were interviewed; partic-
ipation rates varied from 12.9% in Asia to 81.1% in
Poland. Most respondents were female (Table 1).
European respondents were significantly older than Asian
respondents (mean age 47 and 39 years, respectively, range
18–75 years, t = 16.2; degrees of freedom [df] = 3,351;
p<0.001). Overall, 45% of respondents thought they were
likely or very likely to become infected with AI if an out-
break occurred in their country. This perception varied
from 32% in Denmark and Singapore to 61% in Poland
and Spain. Risk perception scores varied significantly
across countries; the highest mean score was in Poland and
the lowest was in Denmark (Table 2). Higher scores were
observed in Europe than in Asia (t = 5.2; df = 3,250;
p<0.001), and differences between individual countries
within Europe were significant. Multivariate analysis
showed that country, sex, and age group remained inde-
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action between country and sex and between country and
age group (Figure). In all countries, except Singapore, risk
perception was higher among women than men, but this
difference was smaller in Asian than in European coun-
tries. The effects of age also varied by country; mean risk
perception levels were higher in older age groups in
Europe but not in Asia.
Response efficacy and self-efficacy also varied across
countries; levels were highest in China and lowest in the
Netherlands (Table 2). Mean response efficacy and self-
efficacy were significantly higher in Asia than in Europe
(response efficacy t = −14; df = 2,868; p<0.001; self-effi-
cacy t = −20; df = 2,701; p<0.001). Response and self-effi-
cacy were inversely associated with risk perception (p =
0.013 and p<0.001, respectively).
Multivariate analysis also showed that country, but not
sex or age, was significantly associated with response effi-
cacy. Country, sex, and age group were all significantly
associated with self-efficacy. Self-efficacy levels were
lower for women compared with men and for the youngest
age group compared with older respondents. Risk percep-
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avian influenza in Europe did not differ significantly.
Conclusions
Our study showed that risk perceptions for AI appear
to be at an intermediate level and that efficacy beliefs are
slightly lower. Both differ according to country or region.
No evidence was found that the introduction of AI in
Europe in October 2005 influenced perceptions of risk or
efficacy.
Fielding et al. have reported on risk perception of AI
in Hong Kong with a focus on live chicken sales (10).
Although our results are difficult to compare with theirs,
our study appears to indicate a higher feeling of vulnera-
bility, with 41.8% of Hong Kong respondents thinking it
likely or very likely that they would become infected with
influenza during an outbreak. Takeuchi’s interviews on
food safety practices of consumers in Thailand found high
levels of knowledge of AI but lower levels of risk percep-
tion and behavior change (11). If we compare our results
with those from several studies on perception of risk for
SARS, we find that perception of risk for SARS in some of
the Asian countries was relatively low compared with that
in the United States (12). In the Netherlands, however, per-
ception of risk for SARS was low, whereas our present
study indicates that it is high for influenza (9).
The lower level of risk perception for AI in Asia may
be related to the proximity to the current outbreak and the
experience with the SARS epidemic. These experiences
may have resulted in the notion that new epidemics of
infectious diseases can be controlled. Also, despite the fact
that the first cases of H5N1 influenza among humans in
Asia were reported in 2003, a larger outbreak did not
ensue. Accordingly, risk perception research has shown
that the public may be more optimistic when familiar risks
are perceived to be largely under volitional control (13,14).
Our study has several implications for public health
policy and research. Although in all countries an influenza
pandemic is perceived as a real risk, the level of self-effi-
cacy appears to be rather low. When developing prepared-
ness plans for an influenza pandemic, specific attention
should therefore be paid to risk communication and how
perceived self-efficacy can be increased; otherwise, adher-
ence to preventive measures may be low.
This work was done as part of SARSControl: Effective and
Acceptable Strategies for the Control of SARS and New
Emerging Infections in China and Europe, a European
Commission project funded within the Sixth Framework
Programme, Thematic Priority Scientific Support to Policies,
contract no. SP22-CT-2004-003824.
Mr de Zwart is head of the Division of Infectious Diseases
Control of the Municipal Public Health Service Rotterdam Area
and PhD candidate at the Department of Public Health, Erasmus
University Medical Center Rotterdam. His research interests
focus on risk perception and communication in relation to infec-
tious diseases and development and evaluation of preventive
DISPATCHES
292 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 2, February 2007
Figure. Mean risk perception by country or region, sex, and age group. Lines, predicted means; squares and circles, observed means;
solid line and circles, male; dashed line and squares, female.interventions for HIV, sexually transmitted infections, and viral
hepatitis.
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